Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LATUDA vs LAZERTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LATUDA vs LAZERTINIB: Safety Overview

Metric LATUDA LAZERTINIB
Total FAERS Reports 130 352
Deaths Reported 10 15
Death Rate 7.7% 4.3%
Hospitalizations 42 83
Average Patient Age 42.5 yrs 66.6 yrs
% Female Patients N/A 59.9%
FDA Approval Date N/A Aug 19, 2024
Manufacturer N/A Janssen Biotech, Inc.
Route N/A ORAL
Marketing Status N/A Prescription